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Profiling
Mycobacterium
ulcerans with
hsp65
To the Editor: Mycobacterium
ulcerans is an emerging human
pathogen responsible for Buruli ulcer,
a necrotizing skin disease most com-
monly found in West Africa, but out-
breaks have also been reported in the
Americas, Australia, and Asia (1).
Environmental sources of infection
and mode of transmission are not
completely known. M. ulcerans
grows slowly at 32°C, requiring 6–8
weeks for colonies to be visible in pri-
mary culture. Differentiation from M.
marinum, which also causes skin
infections, is important, since M. mar-
inum can usually be treated with
antimicrobial agents, whereas M.
ulcerans most often does not respond
favorably to drug therapy, and treat-
ment is usually by surgical excision
(2). M. shinshuense, initially isolated
from a child in Japan, is phenotypical-
ly and genetically related but bio-
chemically distinct from M. ulcerans
(3). 
In the last decade, several DNA-
based techniques for mycobacterial
identification have been developed.
Rapid molecular detection and differ-
entiation of organisms that cause skin
infections directly from tissue or exu-
dates could be of great value for early
treatment. Some techniques, especial-
ly those that include nucleic acid
amplification, could be used directly
on clinical samples. The accepted
standard for molecular identification
of mycobacteria is sequencing analy-
sis of 2 hypervariable regions identi-
fied in 16S rRNA gene. M. marinum
and  M. ulcerans share identical 5′-
16S rDNA and 16S-23S rRNA gene
spacer sequences (4). Polymerase
chain reaction (PCR)-dependent
methods are based on the 16S rRNA
gene (5), the hsp65 gene (6) or the
insertion sequence IS2404 (7).
Recently, a novel category of variable
number tandem repeats that could dis-
tinguish M. marinum and M. ulcerans
genotypes has been described (8).
Polymorphisms in the 3′-16S
rDNA region discriminate M. ulcer-
ans from M. marinum and M. shin-
shuense  (5). These polymorphisms
also allow the separation of M. ulcer-
ans into 3 subgroups according to
geographic origin and variable pheno-
typic differences. IS2404 discrimi-
nates M. ulcerans from M. marinum
(7). It has been used in restriction
fragment length polymorphism analy-
sis applied to a comparable number of
M. ulcerans and M. marinum strains,
confirming that this sequence is pres-
ent in high copy numbers in M. ulcer-
ans  but absent in M. marinum.
Nevertheless, an unusual mycobac-
terium was recently isolated that is
closely related to M. marinum by phe-
notypic tests, lipid pattern, and partial
16S rDNA sequencing but presents
low copy numbers of this element (9).
PCR-restriction enzyme analysis
(PRA) of a 441-bp fragment of the
hsp65 gene is a rapid, easy, and inex-
pensive method for identifying
mycobacteria (10). Devallois et al. (6)
described the PRA-hsp65 pattern of 1
M. ulcerans strain ATCC 33728 that
originated in Japan. This isolate was
considered a new species that resem-
bled M. ulcerans and was named M.
shinshuense (3). 
We report here the usefulness of
PRA-hsp65 to differentiate M. ulcer-
ans strains from different geographic
areas. Since Buruli ulcer cases have
been reported on 5 continents, we
studied 33 M. ulcerans strains that
originated from Africa (Benin, Zaire,
Ghana, Congo, Angola, Côte d’Ivoire,
Togo), Asia (China, Malaysia),
Australia (Papua New Guinea,
Australia), the Caribbean (Mexico,
Surinam, French Guiana), 1 M. shin-
shuense from Japan, 1 M. marinum
isolate and 1 IS2404-positive M. mar-
inum isolate from France (9). All
strains were identified at the Institute
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of Tropical Medicine, the World
Health Organization Collaborating
Centre for the Diagnosis and
Surveillance of Mycobacterium ulcer-
ans Infection by IS2404 PCR and bio-
chemical tests (online Table, available
from http:www.cdc.gov/ncidod/EID/
vol11no11/05-0234.htm#table).
DNA extracted from cultures by 3
freeze-boiling cycles was used for
amplification, according to the proto-
col described by Leao et al. (10). Gel
images were analyzed by using
GelCompar II v. 2.5 (AppliedMaths,
Sint-Martens-Latem, Belgium). Two
distinct M. ulcerans PRA-hsp65 pat-
terns were identified. Of 36 strains, 34
had a PRA-hsp65 pattern indistin-
guishable from that of M. marinum
[BstEII and HaeIII (bp) of 235/210/0
and 145/105/80] at the Swiss PRAsite
(http://app.chuv.ch/prasite/index.html).
Two strains, 1 each from Japan and
China, showed a different pattern
[BstEII and HaeIII (bp) of 235/210/0
and 190/105/80], that described by
Devallois et al. (6).
We have shown that PRA-hsp65
analysis performed on several M.
ulcerans strains from different geo-
graphic areas produced different pat-
terns. In fact, the unique PRA-hsp65
profile of the M. ulcerans strain previ-
ously published (6) was the most
rarely found pattern among the pro-
files found in this study. This work
helps to clarify the PRA-hsp65 pat-
terns of M. ulcerans found in different
countries. Because the epidemiology
of Buruli ulcer is poorly understood,
new molecular tools are still needed to
differentiate M. ulcerans from differ-
ent geographic settings, mainly in
Africa, where the disease is more
prevalent. The PRA-hsp65 method
represents a rapid, easy, and inexpen-
sive technique to differentiate M.
shinshuense from M. ulcerans and M.
marinum. 
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Spelling of
Emerging
Pathogens
To the Editor: Language is about
comprehension; provided the parties
in a discussion can understand each
other, variations in pronunciation of
individual words may be tolerated or
disregarded. In modern English,
numerous examples of variant pro-
nunciations exist that cause no prob-
lems of comprehension (e.g., either,
tomato, laboratory, fertile). These
arise from several causes; regional
practice is likely the most important
factor, but the speaker’s education and
social background, personal prefer-
ences, and even etymologic theories
also play a part. It would be futile and,
some would feel, undesirable to
attempt to impose uniformity by pre-
scribing approved pronunciations if
communication is not endangered.
Moreover, both language and pronun-
ciation are subject to constant change.
The same is not true regarding the
spelling of organisms’ names.
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